×
About 1,949 results

ALLMedicine™ Infantile Hemangioma Center

Research & Reviews  929 results

Propranolol Reduces the Development of Lesions and Rescues Barrier Function in Cerebral...
https://doi.org/10.1161/STROKEAHA.120.029676
Stroke Oldenburg J, Malinverno M et. al.

Feb 23rd, 2021 - Cerebral cavernous malformations (CCM) present as mulberry-like malformations of the microvasculature of the central nervous system. Current medical treatment of CCM lesions is limited to surgical removal of the vascular malformations. It is, ther...

Neonatal Vascular Tumors.
https://doi.org/10.1016/j.clp.2020.11.011
Clinics in Perinatology; Briones M, Adams D

Feb 15th, 2021 - Vascular tumors are a part of the vascular anomalies spectrum. Vascular malformations are congenital vascular lesions, originating from a mesenchymal stem cell defect and distinguished from vascular tumors by their low cell turnover and lack of in...

Parenting Children With a Cleft Lip With or Without Palate or a Visible Infantile Heman...
https://doi.org/10.1177/1055665621993298
The Cleft Palate-craniofacial Journal : Official Publicat... van Dalen M, Leemreis WH et. al.

Feb 15th, 2021 - Parents of children with a medical condition and a visible difference can experience challenging situations. We evaluated distress and parenting stress in parents of children with a cleft lip with or without cleft palate (CL±P) or a visible infant...

Hypoxia-Induced Cyr61/CCN1 Production in Infantile Hemangioma.
https://doi.org/10.1097/PRS.0000000000007672
Plastic and Reconstructive Surgery; Wu P, Xu H et. al.

Feb 15th, 2021 - Hypoxia may play a role in the pathogenesis of infantile hemangioma. Cysteine-rich angiogenic inducer 61 (Cyr61), or CCN1, can be induced under hypoxic conditions in several types of cells. However, whether CCN1 has any impact on infantile hemangi...

Critical role of Aquaporin-1 and telocytes in infantile hemangioma response to proprano...
https://doi.org/10.1073/pnas.2018690118
Proceedings of the National Academy of Sciences of the Un... Moisan F, Oucherif S et. al.

Feb 9th, 2021 - Propranolol, a nonselective β-adrenergic receptor (ADRB) antagonist, is the first-line therapy for severe infantile hemangiomas (IH). Since the incidental discovery of propranolol efficacy in IH, preclinical and clinical investigations have shown ...

see more →

Guidelines  3 results

The Use of ?-Blockers for the Treatment of Periocular Hemangiomas in Infants: A Report by th...
https://www.aaojournal.org/article/S0161-6420(18)31999-7/fulltext
Hutchinson, A.,et al

Jul 31st, 2018 - There is limited evidence to support the safety and efficacy of both topical and systemic ?-blockers to promote regression of periocular hemangiomas. Additional research may confirm the best dosage and route of administration to maximize efficacy.

Diagnosis and Management of Infantile Hemangioma: Executive Summary.
https://doi.org/10.1542/peds.2015-2482
Pediatrics Darrow DH, Greene AK et. al.

Sep 29th, 2015 - Diagnosis and Management of Infantile Hemangioma: Executive Summary.|2015|Darrow DH,Greene AK,Mancini AJ,Nopper AJ, ,|diagnosis,therapy,diagnosis,therapy,

Diagnosis and Management of Infantile Hemangioma.
https://doi.org/10.1542/peds.2015-2485
Pediatrics Darrow DH, Greene AK et. al.

Sep 29th, 2015 - Infantile hemangiomas (IHs) are the most common tumors of childhood. Unlike other tumors, they have the unique ability to involute after proliferation, often leading primary care providers to assume they will resolve without intervention or conseq...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  959 results

Propranolol Reduces the Development of Lesions and Rescues Barrier Function in Cerebral...
https://doi.org/10.1161/STROKEAHA.120.029676
Stroke Oldenburg J, Malinverno M et. al.

Feb 23rd, 2021 - Cerebral cavernous malformations (CCM) present as mulberry-like malformations of the microvasculature of the central nervous system. Current medical treatment of CCM lesions is limited to surgical removal of the vascular malformations. It is, ther...

Neonatal Vascular Tumors.
https://doi.org/10.1016/j.clp.2020.11.011
Clinics in Perinatology; Briones M, Adams D

Feb 15th, 2021 - Vascular tumors are a part of the vascular anomalies spectrum. Vascular malformations are congenital vascular lesions, originating from a mesenchymal stem cell defect and distinguished from vascular tumors by their low cell turnover and lack of in...

Parenting Children With a Cleft Lip With or Without Palate or a Visible Infantile Heman...
https://doi.org/10.1177/1055665621993298
The Cleft Palate-craniofacial Journal : Official Publicat... van Dalen M, Leemreis WH et. al.

Feb 15th, 2021 - Parents of children with a medical condition and a visible difference can experience challenging situations. We evaluated distress and parenting stress in parents of children with a cleft lip with or without cleft palate (CL±P) or a visible infant...

Hypoxia-Induced Cyr61/CCN1 Production in Infantile Hemangioma.
https://doi.org/10.1097/PRS.0000000000007672
Plastic and Reconstructive Surgery; Wu P, Xu H et. al.

Feb 15th, 2021 - Hypoxia may play a role in the pathogenesis of infantile hemangioma. Cysteine-rich angiogenic inducer 61 (Cyr61), or CCN1, can be induced under hypoxic conditions in several types of cells. However, whether CCN1 has any impact on infantile hemangi...

Critical role of Aquaporin-1 and telocytes in infantile hemangioma response to proprano...
https://doi.org/10.1073/pnas.2018690118
Proceedings of the National Academy of Sciences of the Un... Moisan F, Oucherif S et. al.

Feb 9th, 2021 - Propranolol, a nonselective β-adrenergic receptor (ADRB) antagonist, is the first-line therapy for severe infantile hemangiomas (IH). Since the incidental discovery of propranolol efficacy in IH, preclinical and clinical investigations have shown ...

see more →

News  53 results

Timolol shortens propranolol use in infantile hemangioma
https://www.mdedge.com/dermatology/article/202247/dermatology/timolol-shortens-propranolol-use-infantile-hemangioma?channel=276
Christopher Palmer

Jun 4th, 2019 - Sequential therapy of oral propranolol then topical timolol for infantile hemangioma helped shorten duration of propranolol and maintain treatment success, according to a study published in Pediatric Dermatology. hypotekyfidler/Getty Images Diana.

Management of Infantile Hemangiomas Clinical Practice Guidelines (2019)
https://reference.medscape.com/viewarticle/908544

Feb 5th, 2019 - The guidelines on the management of infantile hemangioma were released on December 24, 2018, by the AAP.[1,2] Five indications for early treatment of problematic infantile hemangiomas (IHs) include the following: Life-threatening lesions, such as ...

AAP infantile hemangioma guideline should empower primary care clinicians
https://www.mdedge.com/clinicianreviews/article/192799/dermatology/aap-infantile-hemangioma-guideline-should-empower
Jill D. Pivovarov

Jan 16th, 2019 - The American Academy of Pediatrics has issued its first clinical practice guideline on infantile hemangiomas (IHs), given the dramatic increase in information available over the past decade. The aim in providing an evidence-based approach to evalu.

AAP Guideline Urges Prompt Care for Infantile Hemangiomas
https://www.medscape.com/viewarticle/906955

Dec 23rd, 2018 - In a new clinical practice guideline on the management of infantile hemangioma (IH), the American Academy of Pediatrics (AAP) recommends that infants at high risk for complications receive a referral to a specialist for evaluation and possible tre...

AAP Guideline Urges Prompt Care for Infantile Hemangiomas
https://www.staging.medscape.com/viewarticle/906955

Dec 23rd, 2018 - In a new clinical practice guideline on the management of infantile hemangioma (IH), the American Academy of Pediatrics (AAP) recommends that infants at high risk for complications receive a referral to a specialist for evaluation and possible tre...

see more →

Patient Education  3 results see all →